PAXELADINE

This brand name is authorized in Estonia, France, Lithuania, Romania, Tunisia.

Active ingredients

The drug PAXELADINE contains one active pharmaceutical ingredient (API):

1
UNII 5AEV5C340C - OXELADIN CITRATE
 

Oxeladin is a highly potent and effective drug used to treat all types of cough of various etiologies. It is not related to opium or its derivatives, so treatment with oxeladin is free of risk of dependence or addiction.
 
Read more about Oxeladin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R05DB09 Oxeladin R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DB Other cough suppressants
Discover more medicines within R05DB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1011902, 1865190
FR Base de données publique des médicaments 66856803
LT Valstybinė vaistų kontrolės tarnyba 1007130
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66206001, W66206002
TN Direction de la Pharmacie et du Médicament 9143031

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈